Latest news with #RobBall
Associated Press
21-07-2025
- Business
- Associated Press
Shoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing
GRAND RAPIDS, Mich., July 21, 2025 /PRNewswire/ -- Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the closing of a $40 million convertible notes financing by new investor Fidelity Management & Research Company. Proceeds from the financing will be used primarily to support continued commercialization of Shoulder Innovations' advanced implant systems for anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA), as well as for new product development. Shoulder Innovations' InSet™ Glenoid technology serves as the foundation for the company's aTSA and rTSA implant systems and includes a novel biomechanical design that aims to reduce stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion to specifically address glenoid loosening, a primary problem in shoulder arthroplasty. Both implant systems leverage consistent surgical techniques and the same efficient, two tray instrumentation system. 'Shoulder Innovations is transforming shoulder surgical care with a purpose-built ecosystem, designed to deliver predictable outcomes and procedural efficiency across all sites of care,' said Rob Ball, CEO of Shoulder Innovations. 'We appreciate the support with this investment and believe these proceeds will help us to advance our mission to redefine shoulder arthroplasty and enable best-in-class outcomes for shoulder specialists and their patients.' About Shoulder Innovations: Shoulder Innovations is a medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care. View original content to download multimedia: SOURCE Shoulder Innovations
Forbes
08-07-2025
- Entertainment
- Forbes
Alanis Morissette Charts Her First No. 1 Album Decades Into Her Career
Alanis Morissette's Jagged Little Pill returns to U.K. charts and hits No. 1 on the Official Album ... More Downloads chart, earning the singer her first leader on that list. LONDON, ENGLAND - MARCH 04: Alanis Morissette performs at O2 Shepherd's Bush Empire on March 04, 2020 in London, England. (Photo by Rob Ball/WireImage) It's been 30 years since Alanis Morissette released what would go on to become one of the most successful albums of all time, Jagged Little Pill. The full-length turned her into a global superstar and helped inject the sounds of alternative rock and grunge into top 40 pop radio. Decades later, the project is still regarded as a masterpiece, and this week, it storms the charts in the United Kingdom following the Canadian singer-songwriter's performance at Glastonbury, one of the most important and closely watched music festivals in the world. Alanis Morissette Returns with her Classic Jagged Little Pill appears on half a dozen charts in the U.K. this week, and 30 years into its lifespan, it even manages to lead one of them. Morissette conquers the Official Album Downloads chart with her breakout project, which soars from No. 40 to the top spot following her showstopping performance. A Career First for Alanis Morissette Jagged Little Pill reaches No. 1 on the Official Album Downloads tally for the first time this week. Perhaps even more impressively, Morissette collects her first leader on the list of the most-purchased full-lengths and EPs on download platforms like iTunes and Amazon in the U.K. She had previously peaked at No. 4 with Such Pretty Forks in the Road. Flavors of Entanglement also brought her into the top 10, where it stalled at No. 7. A Second Week Inside the Top 10 Jagged Little Pill earns just its second stay inside the highest tier on the Official Album Downloads chart as it surges. In February 2015, the project reentered the list at No. 6, which stood as its best showing until now. Jagged Little Pill Reaches Several Charts As it hits No. 1 on the Official Album Downloads chart, Jagged Little Pill also launches to impressive positions on both the Official Albums Sales and Official Physical Albums tallies. On the former, it cracks the top 10, shooting more than 60 spaces. On the latter, the project lifts 70-plus spots, though it doesn't quite manage to enter the top 10. At the same time, the Grammy-winning rock set arrives on the Official Albums Streaming ranking and reenters both the Official Vinyl Albums tally and the main list of the most consumed full-lengths and EPs in the U.K.
Yahoo
10-03-2025
- Business
- Yahoo
Shoulder Innovations secures $40m to advance arthroplasty systems
Shoulder Innovations has secured $40m in a Series E equity financing round, to mainly progress the commercialisation of its InSet Total Shoulder and Reverse Shoulder Arthroplasty Systems. The proceeds from the round will also be utilised for general corporate activities and supporting the development of a new product. Current investor US Venture Partners led the funding round, which also saw contributions from current investors such as Gilde Healthcare Partners, Aperture Venture Partners, and Gilmartin Capital, along with Sectoral Asset Management and Arboretum Ventures. Shoulder Innovations CEO Rob Ball said: 'Over recent years, we have significantly expanded our product line, strengthened our sales organisation, and emerged as a pure-play leader in shoulder arthroplasty. 'We appreciate the support of our new and existing investors and see this financing as well-timed as we hone our focus on accelerating commercial momentum and advance our mission of enabling best-in-class outcomes for shoulder specialists and their patients.' The company noted that InSet Glenoid technology is tailored to mitigate glenoid loosening, the primary cause of failure in total shoulder arthroplasty (TSA). By positioning the implant within a sclerotic bone pocket, the InSet Glenoid claims to decrease mechanical stress at the interface of bone and implant, which has been demonstrated through finite element analysis to lessen "rocking horse" stresses by 87%. This method aids surgeons in improving the shoulder implants' longevity. According to the company, the InSet Reverse System provides a reproducible solution for complex shoulder condition management while maintaining biomechanical integrity. Shoulder Innovations focuses on advancing shoulder arthroplasty solutions and aims to enhance patient care and minimise healthcare expenses. "Shoulder Innovations secures $40m to advance arthroplasty systems" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Associated Press
10-03-2025
- Business
- Associated Press
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing
GRAND RAPIDS, Mich., March 10, 2025 /PRNewswire/ -- Shoulder Innovations, a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital, and Aperture Venture Partners. New investors Arboretum Ventures and Sectoral Asset Management also participated. Proceeds from the financing will be used primarily to advance commercialization of the Company's InSet™ Total Shoulder and Reverse Shoulder Arthroplasty Systems and support new product development, as well as for general corporate purposes. 'Over recent years, we have significantly expanded our product line, strengthened our sales organization, and emerged as a pure-play leader in shoulder arthroplasty,' said Rob Ball, CEO of Shoulder Innovations. 'We appreciate the support of our new and existing investors and see this financing as well-timed as we hone our focus on accelerating commercial momentum and advance our mission of enabling best-in-class outcomes for shoulder specialists and their patients.' 'Shoulder Innovations has established compelling clinical credibility with its disruptive and highly differentiated InSet™ technology, and U.S. Venture Partners is pleased to continue supporting the Company by leading this financing round,' said Casey Tansey, General Partner at U.S. Venture Partners. 'Looking ahead, we believe Shoulder Innovations is well-positioned to further advance patient outcomes while delivering economic benefits to healthcare practitioners as a leading innovator in the shoulder arthroplasty market.' About Shoulder Innovations: Shoulder Innovations is a shoulder arthroplasty-focused medical device development company that designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Leveraging its breakthrough, patented InSet™ glenoid design, Shoulder Innovations developed a shoulder replacement implant system focused on improving outcomes related to the greatest cause of anatomic shoulder replacement failure: glenoid loosening. The InSet™ technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplifies the surgical technique, potentially reducing complications or increasing implant longevity. Beyond addressing one of the biggest problems in anatomic shoulder arthroplasty, Shoulder Innovations has also developed the anatomic reverse shoulder system, designed to work with and maximize the available rotator cuff instead of substituting for it.
